Check out Benton Bodamer’s mention in the NBC4i article, “How Ohio restricts medical marijuana advertising.”
- Bodamer, Benton B.
- Media Mentions
Want to get our alerts?
Click “Subscribe Now” to get attorney insights on the latest developments in a range of services and industries.
Check out Benton Bodamer’s mention in the NBC4i article, “How Ohio restricts medical marijuana advertising.” In this article, Benton weighs in on potential advertising obstacles in the Ohio cannabis industry. He states that “heavy marketing restrictions – and the absence of medical marijuana references in the general public – may also insinuate something’s illegal or wrong about consuming the drug... That could serve to continue the stigmatization of marijuana.” To read the full article, click here.
Contacts

Benton Bodamer
Member & Practice Group Chair - Corporate, Private Equity, M&A
Columbus
Recent Insights
- May 21, 2025 In the News Reuters recently published Sara Jodka’s article, “Plastic, fantastic ... and potentially litigious: AI Barbie goes from dollhouse to courtroom.”
- May 21, 2025 In the News Precedent published Daniel Waldman’s article, “The complete guide to life after hireback.”
- May 20, 2025 Industry Alerts Washington State Joins Right-to Repair-Movement
- May 20, 2025 Recognition Kevin Doherty has been named as one of the new members of the Captive Review Hall of Fame
- May 19, 2025 Industry Alerts Plugged In: An EV Newsletter Vol. 3, No. 5
- May 19, 2025 Industry Alerts Suzanne Sukkar delivered the keynote address at the 3rd Annual National Arab American Bar Association – Michigan Chapter (NAABA-MI) Gala 2025. Suzanne was also presented with a State of Michigan Special Tribute award.
- May 19, 2025 Media Mentions Daniel Cotter was recently mentioned in a Bloomberg Law article, “Seventh Circuit Fuels Confusion Around Privacy Insurance Coverage.”
- May 16, 2025 Media Mentions Dickinson Wright was featured in the Law 360 article, “Dickinson Wright Combines With Firm, Opens Seattle Office.”
- May 15, 2025 Industry Alerts Breaking: FDA, HHS Seek Public Input on Cutting Rules